- 100,000,000 Americans have a fatty liver. Most don't know it.
- 20,000,000 will develop liver fibrosis disease or NAFLD (nonalcoholic fatty liver disease) as a result.
- 2,000,000 million will progress to liver cirrhosis or NASH (nonalcoholic steatohepatitis) and end stage liver failure.
- Some will be lucky enough to be listed for a transplant, the only cure for late stage liver disease, but 30% of those listed will die waiting. Death by liver failure is long and difficult.
- We want to help you avoid this kind of death by helping you understand how you may be killing yourself slowly. And, what you can do about it.
- If you are already ill, we will do our best to help you with that process.
To improve the diagnosis, treatment & support of Americans with fatty liver, NAFLD or NASH through awareness, education, screening & advocacy.
About NAFLD & NASH
> This short video, from John's Hopkins Medicine, gives a good overview of nonalcoholic fatty liver disease. Dr. Saleh Alqahtani, director of clinical liver research and assistant professor of medicine, answers questions about the causes, symptoms and treatments.
> In this video, brought to you by THE NASH EDUCATION PROGRAM, internationally renowned opinion leaders address NAFLD (nonalcoholic fatty liver disease) and NASH (nonalcoholic steatohepatits) and their challenges.
> This video is fairly technical, but well worth the time to watch. Dr. Stephen Harrison, Hepatologist and international opinion leader in fatty liver disease and NASH, discusses the evolving landscape of fatty liver disease in the United States as well as diagnostic approaches to identify patients at risk for this disease.